These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27288034)

  • 61. [Treatment of new cases of pulmonary tuberculosis with a combination of isoprodian and ethambutol; clinical results (author's transl)].
    Opl G; Benkö M
    Prax Pneumol; 1977 Feb; 31(2):116-20. PubMed ID: 846937
    [No Abstract]   [Full Text] [Related]  

  • 62. Toxicity and tolerability of fluoroquinolone-based preventive therapy for childhood contacts of multidrug-resistant tuberculosis.
    Seddon JA; Garcia-Prats AJ; Kampmann B; Schaaf HS; Hesseling AC
    Pediatr Infect Dis J; 2014 Oct; 33(10):1098-9. PubMed ID: 25361192
    [No Abstract]   [Full Text] [Related]  

  • 63. [Effectiveness of antibacterial therapy in patients with fibrocavernous tuberculosis inadequately treated in the past].
    Ianovskaia LM; Tarasova EF; Soldatov VE; Mikhaĭlova MM
    Probl Tuberk; 1969; 47(3):19-23. PubMed ID: 5354629
    [No Abstract]   [Full Text] [Related]  

  • 64. [Hepato-digestive tolerance to prothionamide].
    Lesorbre R; Delacoux E; Frey N; Wilmotte F; Legrand M
    Ann Biol Clin (Paris); 1968; 26(5):681-8. PubMed ID: 5681857
    [No Abstract]   [Full Text] [Related]  

  • 65. Gynecomastia caused by ethionamide.
    Sharma PK; Bansal R
    Indian J Pharmacol; 2012; 44(5):654-5. PubMed ID: 23112434
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [GenoType MTBDR plus 1.0® for the detection of cross-resistance between isoniazide and ethionamide in isolates of multidrug-resistant Mycobacterium tuberculosis].
    Rueda J; Realpe T; Mejía G; Zapata E; Robledo J
    Biomedica; 2015; 35(4):541-8. PubMed ID: 26844443
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 68. A comparison of the blood levels and urinary excretion of ethionamide and prothionamide in man.
    Jenner PJ; Ellard GA; Gruer PJ; Aber VR
    J Antimicrob Chemother; 1984 Mar; 13(3):267-77. PubMed ID: 6725176
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of tuberculosis in South Kazakhstan: clinical and economical aspects.
    Maimakov T; Sadykova L; Kalmataeva Z; Kurakpaev K; Šmigelskas K
    Medicina (Kaunas); 2013; 49(7):335-40. PubMed ID: 24375246
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 71. [Use of thioamides in primary and post-primary tuberculosis in children with the exclusion of meningitis].
    Gerbeaux J; Baculard A
    Bull Mem Soc Med Hop Paris; 1965 Nov; 116(15):1575-89. PubMed ID: 5295353
    [No Abstract]   [Full Text] [Related]  

  • 72. [Comparative characteristics of the effectiveness and tolerance of ethionamide and prothionamide in the clinical treatment of pulmonary tuberculosis].
    Bialik IB; Kalabukha AV
    Probl Tuberk; 1973; 51(10):37-40. PubMed ID: 4784035
    [No Abstract]   [Full Text] [Related]  

  • 73. Treatment of leprosy--newer concepts.
    Kaur S; Sharma VK; Kumar B
    Indian J Lepr; 1984; 56(2):307-12. PubMed ID: 6548500
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of
    de Welzen L; Eldholm V; Maharaj K; Manson AL; Earl AM; Pym AS
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993337
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Protionamide tolerance in patients with pulmonary tuberculosis showing poor tolerance to ethionamide].
    Utkin VV; Zankisova IG; Poleshchuk AK; Krylova NP; Gridneva SM
    Vrach Delo; 1971 Nov; 11():79-81. PubMed ID: 5143287
    [No Abstract]   [Full Text] [Related]  

  • 76. Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings.
    Sotgiu G; Tiberi S; Centis R; D'Ambrosio L; Fuentes Z; Zumla A; Migliori GB
    Int J Infect Dis; 2017 Mar; 56():190-193. PubMed ID: 27816662
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The chemotherapy of leprosy. Part 1.
    Ellard GA
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120
    [No Abstract]   [Full Text] [Related]  

  • 78. Effects of ethionamide (TH-1314) and prothionamide (TH-1321) on gastric juice acidity.
    Gupta DK; Agarwal MC; Mittal OP
    Indian J Chest Dis; 1974 Jul; 16(3):163-70. PubMed ID: 4418691
    [No Abstract]   [Full Text] [Related]  

  • 79. [The sensitivity of mycobacteria to 4-4'-diisoamyloxythiocarbanalide (Isoxyl) and its determination in Löwenstein-Jensen medium].
    Meissner G; Stottmeier D
    Beitr Klin Erforsch Tuberk Lungenkr; 1965 May; 130(4):289-95. PubMed ID: 5893629
    [No Abstract]   [Full Text] [Related]  

  • 80. From the Centers for Disease Control. Transmission of multidrug-resistant tuberculosis among immunocompromised persons, correctional system--New York, 1991.
    JAMA; 1992 Aug; 268(7):855-6. PubMed ID: 1640597
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.